FINAXIONResearch
Finaxion Research · “Sell in May and go away” · single stocks · Recomputed 2026-09-10

Does “Sell in May and go away” work on EQIX?

“Sell in May and go away” does not beat buy-and-hold on EQIX: -3.6 points a year over 26 years.

Total return
38.1%
Buy and hold
240.5%
CAGR
1.2%
Sharpe
0.24
Max drawdown
-95.4%
Trades
52
Out of sample
overfit
Years
26
0.01×0.1×1×2001200320052007200920112013201520172019202120232025
StrategyEQIX

Findings

  1. “Sell in May and go away” does not beat buy-and-hold on EQIX: -3.6 points a year over 26 years.
  2. Against the S&P 500 over the same window: -7.2 points a year.
  3. Total return +38.1% versus +240.5% for buy-and-hold, with 52 trades.
  4. The result does not hold out of sample: it is overfit.
  5. Maximum drawdown -95.4%.
  6. It beat before 2013 and stopped afterwards.
  7. It ranks #185 of 232 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact 0b534dd04389.

Exactly what was tested

Long from the first trading day of November to the last of April; cash from May to October. Calendar rules: simulated with our seasonal engine, same costs as everything else.

How to read it

The verdict compares the strategy with buying and holding EQIX over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on EQIX → · Full page for “Sell in May and go away” →

How to cite

Finaxion Research (2026). Does “Sell in May and go away” work on EQIX?. Daily backtest 1962-01-01–2026-08-31, artifact 0b534dd04389. https://finaxion.app/en/research/sell-in-may/eqix

Not a recommendation. Past performance does not guarantee future results.